Evidence map›Paper›PMID 37150147›Full record

ArticleSchizophrenia research2023

The relationship of peripheral inflammation with antibodies to gliadin (AGA IgG) in persons with schizophrenia.

Emily C Daniels, William W Eaton, Daniela Čiháková, Monica V Talor, Hannah Lemke, Chen Mo, Shuo Chen, Francesca M Notarangelo, Katrina M Rodriguez, Deanna L Kelly

Open access · greenAbstract readLetter
In one paragraph

Article in Schizophrenia research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Emily C DanielsMaryland Psychiatric Research Center, University of Maryland School of Medicine, 55 Wade Ave, Catonsville, MD 21228, United States. Electronic address: emilydaniels@som.umaryland.edu.
William W EatonJohns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States. Electronic address: weaton1@jhu.edu.
Daniela ČihákováDepartment of Pathology, Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore, MD 21205, United States. Electronic address: cihakova@jhmi.edu.
Monica V TalorDepartment of Pathology, Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore, MD 21205, United States. Electronic address: mtalor@jhmi.edu.
Hannah LemkeMaryland Psychiatric Research Center, University of Maryland School of Medicine, 55 Wade Ave, Catonsville, MD 21228, United States.
Chen MoMaryland Psychiatric Research Center, University of Maryland School of Medicine, 55 Wade Ave, Catonsville, MD 21228, United States. Electronic address: chen.mo@som.umaryland.edu.
Shuo ChenMaryland Psychiatric Research Center, University of Maryland School of Medicine, 55 Wade Ave, Catonsville, MD 21228, United States. Electronic address: ShuoChen@som.umaryland.edu.
Francesca M NotarangeloMaryland Psychiatric Research Center, University of Maryland School of Medicine, 55 Wade Ave, Catonsville, MD 21228, United States. Electronic address: fnotarangelo@som.umaryland.edu.
Katrina M RodriguezJohns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States. Electronic address: krodri11@jhu.edu.
Deanna L KellyMaryland Psychiatric Research Center, University of Maryland School of Medicine, 55 Wade Ave, Catonsville, MD 21228, United States. Electronic address: dlkelly@som.umaryland.edu.
University of Maryland, Baltimore · USJohns Hopkins University · US

Funding

The Effects of Kynurenine Aminotransferase Inhibition in People with SchizophreniaP50MH103222 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI SCHWARCZ, ROBERT · 2014 to 2023
$25.2M
PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAMT32MH014592 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HEATHER E VOLK, Peter P. Zandi · 1985 to 2026
$8.5M
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin AntibodiesR01MH113617 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI EATON, WILLIAM W, KELLY, DEANNA L · 2017 to 2021
$4.3M
Development for RCT of Gluten Free Diet in Gliadin-Positive SchizophreniaR34MH100776 · NIMH · JOHNS HOPKINS UNIVERSITY · PI EATON, WILLIAM W, KELLY, DEANNA L · 2013 to 2015
$712k
NIMH NIH HHS P50 MH103222NIMH NIH HHS R01 MH113617NIMH NIH HHS R34 MH100776NIMH NIH HHS T32 MH014592
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GliadinSchizophreniaEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GInflammationGliadinImmunoglobulin G

Identifiers

PMID37150147
PMCPMC11912020
OpenAlexW4372279843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.